Quirk Gerald E 4
4 · Syros Pharmaceuticals, Inc. · Filed Feb 14, 2020
Insider Transaction Report
Form 4
Quirk Gerald E
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-13+94,000→ 94,000 totalExercise: $7.54Exp: 2030-02-12→ Common Stock (94,000 underlying)
Footnotes (1)
- [F1]This option becomes exercisable as to 25% of the shares on February 28, 2021, with the remainder vesting in equal monthly installments of 2.0833% of the shares underlying the award at the end of each successive month thereafter.